Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab

Affiliations

¹ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Department of Internal Medicine, Hôpital Foch, Suresnes, France. Electronic address: m.groh@hopital-foch.com.
² Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive-Réanimation, Paris, France; Sorbonne Université, APHP, Hôpital La Pitié-Salpêtrière, Institut E3M, Service de Médecine Interne 2; Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-Immunes Systémiques Rares, Paris, France; Sorbonne Université, INSERM, UMRS_1166-ICAN, Institut de Cardiométabolisme et Nutrition (ICAN), Paris, France.
³ Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France.
⁴ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Clinical Research Department, Hôpital Foch, Suresnes, France.
⁵ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Université de Lille, CHU Lille, Institut d'Immunologie, Lille, France.
⁶ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Université Paris Saclay, Department of Internal Medicine, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
⁷ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Department of Respiratory Medicine, Hôpital Foch, Suresnes, France.

Case Reports

Matthieu Groh et al. J Allergy Clin Immunol Pract. 2021 Sep.

. 2021 Sep;9(9):3497-3499.e1.

doi: 10.1016/j.jaip.2021.04.067. Epub 2021 May 18.

¹ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Department of Internal Medicine, Hôpital Foch, Suresnes, France. Electronic address: m.groh@hopital-foch.com.
² Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive-Réanimation, Paris, France; Sorbonne Université, APHP, Hôpital La Pitié-Salpêtrière, Institut E3M, Service de Médecine Interne 2; Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-Immunes Systémiques Rares, Paris, France; Sorbonne Université, INSERM, UMRS_1166-ICAN, Institut de Cardiométabolisme et Nutrition (ICAN), Paris, France.
³ Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France.
⁴ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Clinical Research Department, Hôpital Foch, Suresnes, France.
⁵ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Université de Lille, CHU Lille, Institut d'Immunologie, Lille, France.
⁶ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Université Paris Saclay, Department of Internal Medicine, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
⁷ National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Department of Respiratory Medicine, Hôpital Foch, Suresnes, France.

No abstract available

Publication types